Global Generic Drugs Strategic Business Report 2023: Market to Reach $671.5 Billion by 2030 - U.S. Market is Estimated at $122.8 Billion, While China is Forecast to Grow at 8.2% CAGR
October 20, 2023 06:03 ET
|
Research and Markets
Dublin, Oct. 20, 2023 (GLOBE NEWSWIRE) -- The "Generic Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Generic Drugs Market to Reach...
Berkshire Sterile achieves its first commercial drug approval by the FDA
March 22, 2022 10:00 ET
|
Berkshire Sterile Manufacturing
Lee, MA, March 22, 2022 (GLOBE NEWSWIRE) -- On March 1, 2022, a long-term client of Berkshire Sterile Manufacturing (BSM) announced the FDA approval of their Abbreviated New Drug Application (ANDA)...
AMRN INVESTOR NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Amarin Corporation plc Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AMRN
December 02, 2021 19:45 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 02, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Amarin Corporation plc (NASDAQ: AMRN) between December 5,...
ROSEN, A LONGSTANDING LAW FIRM, Encourages Amarin Corporation plc Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AMRN
October 29, 2021 17:34 ET
|
The Rosen Law Firm PA
NEW YORK, Oct. 29, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Amarin...
Global $650+ Billion Generic Drugs Market to 2025: Competitive Landscape, Trends, Structure, Recent Mergers and Acquisitions, Brand Name Company Involvement
May 31, 2021 06:48 ET
|
Research and Markets
Dublin, May 31, 2021 (GLOBE NEWSWIRE) -- The "Global Generic Drugs Market 2020-2025" report has been added to ResearchAndMarkets.com's offering. The global market for generic drugs should grow...
Jubilant Receives Favorable Rulings from the U.S. Patent Office Invalidating Bracco Rubidium-Infusion-System Patents
February 17, 2020 08:00 ET
|
Jubilant Pharma
YARDLEY, Pa., Feb. 17, 2020 (GLOBE NEWSWIRE) -- On February 7, 2020, Jubilant DraxImage Inc., and certain of its affiliates (“Jubilant”) were informed by the U.S. Patent Office that it agreed with...
SunGen Pharma Receives Eighth ANDA Approval from US FDA
October 31, 2019 13:51 ET
|
SunGen Pharma LLC
PRINCETON, N.J., Oct. 31, 2019 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products,...
SunGen Pharma 制药获得美国 FDA 的第八个 ANDA 批准
October 31, 2019 13:51 ET
|
SunGen Pharma LLC
新泽西州普林斯顿市, Nov. 01, 2019 (GLOBE NEWSWIRE) -- 2019 年 10 月 31 日: SunGen Pharma, 一家私人控股的研发，生产，和销售制剂产品的制药公司,今天宣布其已获得美国食品与药物管理局（FDA）的第八个 ANDA文号批准。 第八个ANDA的产品名为利多卡因软膏 5% (Lidocaine Ointment USP 5%),...
SunGen Pharma 製藥獲得美國 FDA 的第八個 ANDA 批准
October 31, 2019 13:51 ET
|
SunGen Pharma LLC
新澤西州普林斯頓市, Nov. 01, 2019 (GLOBE NEWSWIRE) -- SunGen Pharma, 一家私人控股的研發，生產，和銷售製劑產品的製藥公司,今天宣布其已獲得美國食品與藥物管理局（FDA）的第八個ANDA文號批准。 第八個ANDA的產品名為利多卡因軟膏 5% (Lidocaine Ointment USP 5%), 每管規格為1.5盎司（35.44克）...
Elite Pharmaceuticals and SunGen Pharma File ANDA for an Antibiotic
January 03, 2019 07:30 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and...